Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 11
2008 5
2009 36
2010 73
2011 79
2012 102
2013 139
2014 143
2015 175
2016 221
2017 255
2018 247
2019 318
2020 351
2021 284
2022 283
2023 210
2024 67

Text availability

Article attribute

Article type

Publication date

Search Results

2,586 results

Results by year

Filters applied: . Clear all
Page 1
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.
Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Niu S, Wang Y, Zhao X, Li Z, Jiang Y, Li W, Liu L, Xu J, Chang L, Wang L, Zhuang X, Zhao J, Feng Y, Man H, Li G, Wang B; CHANCE-2 Investigators. Wang Y, et al. N Engl J Med. 2021 Dec 30;385(27):2520-2530. doi: 10.1056/NEJMoa2111749. Epub 2021 Oct 28. N Engl J Med. 2021. PMID: 34708996 Clinical Trial.
Ticagrelor.
Kabil MF, Abo Dena AS, El-Sherbiny IM. Kabil MF, et al. Profiles Drug Subst Excip Relat Methodol. 2022;47:91-111. doi: 10.1016/bs.podrm.2021.10.003. Epub 2021 Dec 7. Profiles Drug Subst Excip Relat Methodol. 2022. PMID: 35396017 Review.
Ticagrelor-Associated Urticaria.
Zaidi SMJ, Ishaq U, Malik J, Nadir M, Almas T. Zaidi SMJ, et al. Am J Ther. 2023 Nov-Dec 01;30(6):e580-e583. doi: 10.1097/MJT.0000000000001523. Epub 2022 May 31. Am J Ther. 2023. PMID: 35639409 No abstract available.
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.
Angiolillo DJ, Cao D, Sartori S, Baber U, Dangas G, Zhang Z, Vogel B, Kunadian V, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Ielasi A, Stefanini GG, Pivato CA, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R. Angiolillo DJ, et al. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2514-2524. doi: 10.1016/j.jcin.2023.08.019. JACC Cardiovasc Interv. 2023. PMID: 37879803 Clinical Trial.
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
Mendieta G, Mehta S, Baber U, Angiolillo DJ, Briguori C, Cohen D, Collier T, Dangas G, Dudek D, Escaned J, Gil R, Vogel B, Cao D, Spirito A, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Moliterno DJ, Ohman EM, Sardella G, Sartori S, Sharma S, Shlofmitz R, Steg PG, Han YL, Pocock S, Gibson CM, Mehran R. Mendieta G, et al. J Am Coll Cardiol. 2023 Aug 22;82(8):687-700. doi: 10.1016/j.jacc.2023.05.062. J Am Coll Cardiol. 2023. PMID: 37587580 Clinical Trial.
Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
Sandner S, Redfors B, Angiolillo DJ, Audisio K, Fremes SE, Janssen PWA, Kulik A, Mehran R, Peper J, Ruel M, Saw J, Soletti GJ, Starovoytov A, Ten Berg JM, Willemsen LM, Zhao Q, Zhu Y, Gaudino M. Sandner S, et al. JAMA. 2022 Aug 9;328(6):554-562. doi: 10.1001/jama.2022.11966. JAMA. 2022. PMID: 35943473 Free PMC article.
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
Pan Y, Meng X, Jin A, Johnston SC, Li H, Bath PM, Xie X, Jing J, Lin J, Wang Y, Zhao X, Li Z, Jiang Y, Liu L, Yang H, Cheng J, Wang Z, Wang Y. Pan Y, et al. JAMA Neurol. 2022 Aug 1;79(8):739-745. doi: 10.1001/jamaneurol.2022.1457. JAMA Neurol. 2022. PMID: 35727586 Free PMC article. Clinical Trial.
Ticagrelor in stable coronary disease.
van Nunen LX, Johnson NP. van Nunen LX, et al. Heart. 2023 Dec 20;110(2):77-78. doi: 10.1136/heartjnl-2023-323034. Heart. 2023. PMID: 37586825 No abstract available.
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
Kim CJ, Park MW, Kim MC, Choo EH, Hwang BH, Lee KY, Choi YS, Kim HY, Yoo KD, Jeon DS, Shin ES, Jeong YH, Seung KB, Jeong MH, Yim HW, Ahn Y, Chang K; TALOS-AMI investigators. Kim CJ, et al. Lancet. 2021 Oct 9;398(10308):1305-1316. doi: 10.1016/S0140-6736(21)01445-8. Lancet. 2021. PMID: 34627490 Clinical Trial.
2,586 results